Dr. Vanesa Nozal García, from Valladolid in Spain, works as a postdoctoral researcher at the University of Antwerp. Under supervision of Professor Pieter Van Der Veken in the Laboratory of Medicinal Chemistry, she researches Acute Myeloid Leukemia (AML) and focusses on a new methodology: targeted protein degradation.